Trial intelligence / Profile preview

Phase II first-line panitumumab plus capecitabine in elderly patients with metastatic colorectal cancer and wild-type KRAS

2012-000751-13Phase 2Completed

Sponsor

Grupo Gallego de Investigación en Tumores Digestivos

Start

Apr 2012

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1